Nine health and life sciences startups and teams with high growth potential have been selected to join Health Incubator Helsinki. The new batch started their incubator journey in May 2025.

Health Incubator Helsinki is a long-term incubator program driving transformation of health innovation, research findings, and expertise into international business while attracting new talent to Helsinki. The concept is unique in the Nordics in its focus and duration: the incubator focuses solely on health-related startups, and the program lasts up to three years.

For the sixth incubator program, Health Incubator Helsinki received 40 applications representing a wide range of health-related businesses. While the majority of the applications came from Finland, the program also attracted interest from the Nordics and beyond, including Germany, Switzerland, Turkey and India.

AI taking center stage in healthcare innovation

A defining theme of this year’s applications was the rapid evolution of artificial intelligence in healthcare. Many teams are now leveraging AI to tackle pressing challenges, ranging from streamlining clinical documentation to enhancing mental health care.

After the interviews, the following companies and teams were selected to join the program: Doc To Doc Oy, Eipha Biosciences UAB, Innofend Oy, MultivisionDx, Ronroo Oy, Scopia Oy, Uoma Mind Oy, Viseur AI, and 4 Mind Health.

“We paid special attention to whether the teams are solving real-world problems and their potential for international scalability,” says Christian Lardot, Health Incubator Helsinki Lead. “A viable idea and an excellent team go hand in hand. All the teams we selected demonstrate strong dedication and the skillset required for success.”

Up to 3 years of customized mentoring and advice

The sixth Health Incubator Helsinki program kicked off in early May, when the new batch gathered at the Meilahti campus area to dive into the program and get to know each other. The program now continues with a two-month onboarding phase focused on strengthening fundamentals: developing product and service concepts and securing funding.

Following this phase, teams will receive individually tailored support alongside training sessions, webinars, and investor meetings open to all participants.

“After the onboarding, we interview each new team to identify the core areas where they need assistance. Depending on the topic, we help them move forward either with the support of our advisor team or by connecting the company with relevant experts from our wide network,” Lardot explains.

​​Training sessions also reflect startups’ requests.

“While each team is at a slightly different stage, many face similar challenges. We regularly assess what companies need and organize webinars and workshops accordingly.”

Growing need for support

In recent years, access to funding has become increasingly challenging for startups. At the same time, the demand for new health innovations continues to grow – both in Finland and globally. In the health sector, defined by complex regulatory requirements and the need for substantial funding, this highlights the critical role of long-term support programs like Health Incubator Helsinki.

“We have a strong track record of supporting our startups. Last year alone, Health Incubator Helsinki companies raised a total of 11 million euros. We’re excited to see what we’ll achieve together with this new batch of promising startups and teams,” Lardot says.

Meet the 2025 batch of Health Incubator Helsinki startups

DocToDoc Oy 
DocToDoc is an AI-powered smart documentation assistant built for doctors, especially those working in a second language. DocToDoc is the only solution combining multilingual medical translations with documentation support that fits naturally into doctors’ daily routines.

Eipha Biosciences, UAB
Scopia is a Finnish digital‑health startup turning colonoscopy quality data into real‑time insight to prevent colorectal cancer, the world’s second‑deadliest cancer. Its cloud platform records key procedure details in seconds and displays live dashboards so clinicians can raise adenoma‑detection rates and eliminate the 7 % of cancers that slip through sub‑optimal exams. Already deployed in Finnish hospitals with full GDPR compliance, Scopia lets endoscopy teams focus on patients while the software quietly lifts the bar on quality.

Innofend
Innofend is a biotech spin-off from Tampere University developing next-generation vaccines against pandemic viruses. The team’s lead product is a proprietary enterovirus platform using virus-like particles (VLPs). The technology can safely and efficiently generate protective immune responses, even against viruses that can’t be targeted using traditional methods. Innofend is combining innovative science with scalability to close critical gaps in vaccine development.

MultivisionDx 
MultivisionDx aims to transform personalized diagnosis and treatment selection for cancer patients. The MultivisionDx computer vision workflow analyzes images of tumor biopsies, generating patient-specific tumor profiles describing the unique biology of each patient’s disease. This approach enables clinicians to assess tumor aggressiveness and tailor treatment strategies for individual patients.

Ronroo 
Ronroo is a psychoeducation app that offers easy-to-reach support for people with self-control and executive functioning difficulties. Rather than a habit tracker or task manager, it teaches users skills and strategies with personalized learning pathways that adapt to users’ values and circumstances. Developed by a team of experts who are themselves neurodivergent, Ronroo is a research-based support system that makes self-regulation accessible for all.

Scopia
Scopia is a Finnish digital‑health startup turning colonoscopy quality data into real‑time insight to prevent colorectal cancer, the world’s second‑deadliest cancer. Its cloud platform records key procedure details in seconds and displays live dashboards so clinicians can raise adenoma‑detection rates and eliminate the 7 % of cancers that slip through sub‑optimal exams. Already deployed in Finnish hospitals with full GDPR compliance, Scopia lets endoscopy teams focus on patients while the software quietly lifts the bar on quality.

Uoma Mind
Uoma is the first AI-powered narrative therapy app designed to help individuals struggling with stress, anxiety, and emotional challenges. Unlike traditional mental health apps, Uoma transforms users’ spoken reflections into personalized therapeutic stories, helping them reframe their struggles, gain clarity, and track their emotional growth over time. Available 24/7, Uoma provides a private, structured, and engaging way to process emotions—making therapy more accessible, reflective, and empowering.

Viseur AI
Viseur AI supports the AI transformation in the healthcare sector by providing an all-in-one / no-code artificial intelligence development ecosystem (SaaS) in the field of medical imaging. It offers services that enable healthcare professionals to develop their own AI products for diagnostic and therapeutic purposes in radiology and digital pathology, and to utilize these products in their clinical environments.

4MindHealth
4MindHealth delivers consumer-focused mental health solutions through hard technology and innovative service models. The company is building an ecosystem that bridges easily approachable, even exciting, biomarkers and behavioural nudges on the mobile with digital care delivery. The business model thrives on a combination of data volume from the company’s Asian target markets and clinical expertise from the Finnish home base.

Contact information

Christian Lardot, Health Incubator Helsinki Leader
Tel. +358 40 195 2639
christian.lardot@hel.fi